Hyperbare Zuurstoftherapie: Rapid Assessment - KCE

More documents

Recommendations

Info

6 Hyperbaric Oxygenation Therapy <strong>KCE</strong> Reports 74 OPS Operationen- und Prozedurenschlüssel PCI Percutaneous Coronary Intervention PTA Pulse Tone Average PtcO2 Transcutaneous oxygen pressure measurement QALY Quality-Adjusted Life Year QoL Quality of Life RCT Randomised Controlled Trial RIZIV / INAMI Rijksinstituut voor Ziekte en Invaliditeits Verzekering / Institut National d'Assurance Maladie - Invalidité RNZN Royal New Zealand Navy RR Relative Risk RVU Relative Value Unit SD Standard Deviation SE Standard Error SF-36 Short-Form General Health Survey Sv Sievert (measure of effective radiation dose) TGR / CTM Technische Geneeskundige Raad / Conseil Technique Medical UHMS Undersea and Hyperbaric Medical Society UK United Kingdom (Great Britain) US United States of America VDD Verband Deutscher Druckkammerzentren VGE Venous Gas Embolism ZBC Zelfstandige Behandelcentra
<strong>KCE</strong> Reports 74 Hyperbaric Oxygenation Therapy 7 1 INTRODUCTION Hyperbaric Oxygen Therapy (HBOT) is the administration of oxygen at pressures greater than normal atmospheric pressure for therapeutic reasons. It is defined by the Undersea and Hyperbaric Medical Society (UHMS) as ‘a treatment in which a patient breathes 100% oxygen while inside a treatment chamber at a pressure higher than sea level pressure, i.e. more than 1 atmosphere absolute (ATA). Hyperbaric oxygenation can also be applied as a diagnostic procedure to decide on the appropriateness of HBOT. The treatment is performed in pressure chambers of various sizes, ranging from monoplace chambers for one patient only, to multiplace or multi-compartment treatment chambers in which several patients can sit and where hospital beds or even an entire intensive care setting can be installed and where health workers can attend to the patients. Recompression with normal air was initially intended as a treatment for decompression sickness (DCS). In the late 19 th century ‘caisson disease’ became a frequent illness in workers involved in large construction projects (bridges, tunnels) where they had to work in hyperbaric conditions while labouring in ‘caissons’. Mortality from this disease, also called bubble disease, was greatly reduced thanks to recompression therapy with normal air. Halfway the 20 th century, the use of normal air was replaced by the use of either pure oxygen or specific mixtures of gasses, and HBOT established itself as standard therapy for all types of decompression illness (DCI) caused by diving, aviation or of iatrogenic origin. Although it was known for a long time that breathing oxygen under increased ambient pressure could lead to an increased amount of oxygen in the blood, the medical use of HBOT for the treatment of conditions other than DCI only started about 50 years ago, when the Dutch cardiac surgeon Ite Boerema reported on the use of hyperbaric oxygen during paediatric cardiac surgery. This marked the beginning of a proliferation of hyperbaric chambers in hospitals around the world. During this era numerous new indications were proposed, from CO poisoning to the treatment of senility and the conservation of youthfulness. Many of the reported indications were based on little or no evidence and it was during this period that HBOT gained a reputation of quackery with many in the medical community. Recently, RCTs were performed for specific indications and evidence on certain indications has appeared. It is the aim of this report to bring together this evidence, to examine the health-economic aspects of HBOT, to describe current practice and organisation in Belgium and to make recommendations for the most appropriate use of this therapeutic technology in this country.
Page 1 and 2: Hyperbare Zuurstoftherapie: Rapid A
Page 3 and 4: Hyperbare Zuurstoftherapie: Rapid A
Page 5 and 6: KCE Reports 74A Hyperbare Zuurstoft
Page 7 and 8: KCE Reports 74A Hyperbare Zuurstoft
Page 9: KCE Reports 74A Hyperbare Zuurstoft
Page 12 and 13: 2 Hyperbaric Oxygenation Therapy KC
Page 20 and 21: 10 Hyperbaric Oxygenation Therapy K
Page 66 and 67:
56 Hyperbaric Oxygenation Therapy K
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
KCE Reports 74 Hyperbaric Oxygenati
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Wettelijk depot : D/2008/10.273/13
Page 132:
38. Baarmoederhalskankerscreening e
show all

Hyperbare Zuurstoftherapie: Rapid Assessment - KCE

Create successful ePaper yourself

Delete template?

Save as template?